Sam Fazeli

Sam Fazeli

Dir:Research Global Industries/Senior Pharmaceutical Analys

Sam Fazeli is Director of Research for Global Industries and Senior Pharmaceuticals Analyst

Latest

Monoclonal Antibody Treatment In Demand Amid Rise In Covid-19 Cases

Bloomberg Opinion

What Covid Treatment Will Cost You in 2023

The US government will soon stop paying for vaccines, monoclonal antibodies and drugs like Paxlovid. That's bad news for already-weak demand.

September 8, 2022

September 8, 2022

OpinionLisa Jarvis and Sam Fazeli

What Covid Treatment Will Cost You in 2023

The US government will soon stop paying for vaccines, monoclonal antibodies and drugs like Paxlovid. That's bad news for already-weak demand.

Monoclonal Antibody Treatment In Demand Amid Rise In Covid-19 Cases

August 23, 2022

August 23, 2022

OpinionTherese Raphael and Sam Fazeli

College Kids and Pet Owners Should Beware Monkeypox Too

The outbreak has proved more persistent than many thought, and governments have been slow to roll out vaccines. We can’t lose vigilance in the back-to-school rush.

Florida's Miami-Dade County Opens Two New Monkeypox Vaccine Sites As Outbreak Grows

August 19, 2022

August 19, 2022

OpinionTherese Raphael and Sam Fazeli

Britain Needs a Better Booster Strategy for Covid

The UK’s successful vaccine rollout is giving way to a scattershot approach.

National Covid Memorial Wall London

July 28, 2022

July 28, 2022

OpinionTherese Raphael and Sam Fazeli

Why an Up-Your-Nose Covid Spray Will Be Costly

Nasal vaccines against the coronavirus variants are both promising and elusive.

A child is restrained as he receives a n

July 1, 2022

July 1, 2022

OpinionTherese Raphael and Sam Fazeli

Why You'll Probably Get Covid (Again) Soon

Despite the general easing of restrictions, the pandemic isn’t over. Most vaccinated people will find the biggest risk is reinfection this winter.

Vaccination Of Children Aged 5 To 11 Years Against COVID-19 Begins In Mexico City

May 31, 2022

May 31, 2022

OpinionTherese Raphael and Sam Fazeli

AstraZeneca + Pfizer Vaccines = Better Omicron Immunity

The UK's mix-and-match approach to vaccinations looks accidentally brilliant.

NHS Begins Spring Booster COVID Vaccination Programme

May 24, 2022

May 24, 2022

OpinionSam Fazeli

How Prepared for a Monkeypox Outbreak Are We?

Monkeypox isn’t a new disease in the same way Covid-19 was. That means we’re in a much better position.

U.S. Soldiers Receive Smallpox Vaccine

May 23, 2022

May 23, 2022

OpinionTherese Raphael and Sam Fazeli

The Woman Who Made the UK a World-Beater in Genomics

Sharon Peacock, the microbiologist who pioneered Britain’s genomics sequencing effort in the pandemic, talks about why sequencing still matters.

Coronavirus Testing Laboratory In Glasgow

May 19, 2022

May 19, 2022

OpinionTherese Raphael and Sam Fazeli

What Is Monkeypox and Should We Be Worried About It?

Cases of a rare virus related to smallpox have been reported in the US, UK, Canada and Spain. Here’s what we know.

What Is Monkeypox and Should We Be Worried About It?

March 31, 2022

March 31, 2022

China Crushed Covid. But Covid Zero Could Crush China

A new wave of infections is highlighting the growing cost of China’s zero-tolerance virus policy

China Crushed Covid. But Covid Zero Could Crush China

March 30, 2022

March 30, 2022

OpinionTherese Raphael and Sam Fazeli

The Covid Era Has More Diabetes and Brain Fog

Covid infections raise the risk of diabetes, neuropsychological issues and long Covid. But we don’t really understand how.

CHINA-HEALTH-VIRUS

March 22, 2022

March 22, 2022

OpinionTherese Raphael and Sam Fazeli

Covid’s Fifth Wave Shows Us How to Live With the Virus

Not all countries are impacted equally by the BA.2 subvariant. That tells us a lot about what works and what doesn’t.

China Steps Up Measures To Control COVID Outbreaks

March 6, 2022

March 6, 2022

OpinionTherese Raphael and Sam Fazeli

Two Ways to Escape China's Zero Covid Trap

China will require mass distribution of an existing mRNA booster shot along with antivirals to adapt.

Two Ways to Escape China's Zero Covid Trap

February 8, 2022

February 8, 2022

OpinionTherese Raphael and Sam Fazeli

Omicron Poses a Puzzle for Vaccine Makers

Early studies show the omicron vaccine isn’t an improvement and a broader vaccine will take longer to develop.

PHILIPPINES-HEALTH-VIRUS

February 2, 2022

February 2, 2022

OpinionTherese Raphael and Sam Fazeli

What We Know About Fast-Spreading Omicron Subvariant BA.2

The omicron variant has a faster-spreading subvariant that is becoming dominant in Denmark and increasing in the U.K.

Covid-19 Testing Facilities At Schiphol Airport

January 27, 2022

January 27, 2022

OpinionTherese Raphael and Sam Fazeli

Why An Omicron-Specific Vaccine Is Worth Testing

A jab targeting a specific variant may help against high rates of reinfection, but it needs to work better than existing vaccines.

INDIA-HEALTH-VIRUS

January 19, 2022

January 19, 2022

OpinionTherese Raphael and Sam Fazeli

Why China Can’t Loosen Up on Covid Zero Yet

Without rolling out masses of mRNA vaccine shots, the country will likely be trapped in costly lockdowns.

China Steps Up Measures To Control COVID Outbreaks

January 12, 2022

January 12, 2022

OpinionTherese Raphael and Sam Fazeli

Say Goodbye to Self-Isolating, WFH Mandates, Mass Testing

It’s time to rethink our Covid response to account for higher vaccination rates, natural immunity and milder variants like omicron.

Medical Staff Works At COVID-19 Testing Center In Houston Amid Surge In Pandemic

December 17, 2021

December 17, 2021

OpinionTherese Raphael and Sam Fazeli

Omicron Presents a Major Challenge for China

Countries that used so-called killed-virus vaccines may have an even greater need for booster shots.

Prevention And Control Measures Against COVID-19 In Shaoxing

December 13, 2021

December 13, 2021

OpinionTherese Raphael and Sam Fazeli

A Fourth Shot Against Omicron? Don’t Count It Out

Pfizer CEO Albert Bourla says we’ll likely need another shot sooner rather than later. But what kind?

Get ready for more.